RT Conference Proceedings
T1 Role of early circulating tumour cell (CTC) monitoring for prediction of clinical outcome in patients with HER-2 negative metastatic breast cancer receiving first-line treatment with bevacizumab and paclitaxel
A1 Alvarez-Lopez, I.
A1 Gonzalez, E.
A1 Manso, L. M.
A1 Alonso, J. L.
A1 Cruz-Hernandez, J. J.
A1 Caranana Ballerini, V.
A1 Gallegos, I.
A1 Quindos Varela, M.
A1 Illaramendi, J. J.
A1 Vicente, E.
A1 Ballesteros Garcia, A. I.
A1 Ayala de la Pena, F.
A1 Perello, A.
A1 Vidal, J.
A1 Llombart Cussac, A.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-05-01
LK https://hdl.handle.net/10668/26246
UL https://hdl.handle.net/10668/26246
LA en
DS RISalud
RD Apr 18, 2025